Novabay Pharmaceuticals Inc Institutionelles Eigentum
Was ist das Institutionelles Eigentum von Novabay Pharmaceuticals Inc?
Institutionelles Eigentum von Novabay Pharmaceuticals Inc ist 2.57%
Was ist die Definition von Institutionelles Eigentum?
Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutionelles Eigentum von Unternehmen in Health Care Sektor auf NYSEMKT im Vergleich zu Novabay Pharmaceuticals Inc
Was macht Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Unternehmen mit institutionelles eigentum ähnlich Novabay Pharmaceuticals Inc
- M.R.M. SA hat Institutionelles Eigentum von 2.56%
- TINC Comm. VA hat Institutionelles Eigentum von 2.56%
- Outcrop Gold hat Institutionelles Eigentum von 2.56%
- iDreamSky Technology hat Institutionelles Eigentum von 2.56%
- Jaiprakash Power Ventures hat Institutionelles Eigentum von 2.57%
- Gocl L hat Institutionelles Eigentum von 2.57%
- Novabay Pharmaceuticals Inc hat Institutionelles Eigentum von 2.57%
- Kaya hat Institutionelles Eigentum von 2.57%
- Union Financière de France Banque SA hat Institutionelles Eigentum von 2.57%
- POET Technologies hat Institutionelles Eigentum von 2.57%
- iShares ETF (CH) - iShares Core SPI (CH) hat Institutionelles Eigentum von 2.57%
- Stanley Furniture hat Institutionelles Eigentum von 2.57%
- River City Bank hat Institutionelles Eigentum von 2.58%